Neos Therapeutics, Inc. (NEOS)

[chainma1l]

Cash flow positive SOON.

Neos' financial position is sound, and we do not need PDL's financial support to achieve our value creation objectives. Neos recently raised approximately $34.5 million through a public offering and had $78.6 million of cash, cash equivalents and short-term investments as of June 30, 2017, which we believe is sufficient to support Neos' operations until they are cash flow positive based on current business plans.

Great news. Of course things change, but NEOS is executing and things are already proceeding according to their plan.